Trouble reading this email? View it in your browser
European Federation of Pharmaceutical Industries and Associations EFPIA Newsletter 29 February 2024
      Rare Disease Day 2024
 
 
#WeWontRest
 

Discover how we are supporting innovation in rare disease:

  • Imagining a future where rare diseases patients have a better chance at a healthy life, an oped by Nathalie Moll, EFPIA Director General
  • Advancing innovation for rare disease patients: a call to action on Rare Disease Day 2024, an oped by Ricardo Marek, President Europe and Canada at Takeda
  • Rare Disease Moonshot supports the EURORDIS-Rare Diseases Europe’s call for an EU action plan
Read more →
 
 
      News
 
  26 February 2024 ‘The draft text of the European Health Data Space (EHDS) in trilogues sparks deep concerns...

The draft text of the European Health Data Space (EHDS) in trilogues sparks deep concerns in the European healthcare...

Read more →
 
 
 
  23 February 2024 WTO Ministerial Conference in Abu Dhabi an opportunity to strengthen trade and health agenda...

A joint statement calling on trade ministers to commit to a comprehensive trade and health agenda that will strengthen...

Read more →
 
 
 
      Blogs
 
  26 February 2024 For healthcare to be sustainable, it must work for innovators, healthcare systems and patients...

Properly designed policies can reward innovation, drive value and improve patients’ access to medicines.

Read more →
 
 
 
      Events
 
 
06 MAR 2024
  REMEDi4ALL International Drug Repurposing Conference Barcelona

Bridging boundaries: Innovating, connecting & reshaping drug repurposing

Learn more →
 
 
 
07 MAR 2024
  Digitally-enabled healthcare: Is our ecosystem on track? Brussels and online

Organised by the EU Health Coalition.

Learn more →
 
 
 
12 APR 2024
  EU-X-CT Public Stakeholders' Forum Brussels and online

Making cross-border access to clinical trials a reality

Learn more →
 
 
 
16 APR 2024
  Rare Diseases Forum: Securing Europe’s competitiveness in R&D for people living with... Brussels

Join to address how and why innovation in tackling rare diseases can support the EU’s competitiveness agenda.

Learn more →
 
 
      What we are reading
Belgium’s De Croo calls for EU ‘Nasdaq’ to boost biotech 27 February 2024  (Politico) Read more →
New rare diseases action plan on horizon, Europe at turning point 27 February 2024  (Euractiv) Read more →
European trade in pharmaceutical goods 18 February 2024  (copenhageneconomics.com) Read more →
    About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

 
Tel: +32 (0)2 626 25 55
Communications@efpia.eu
▶ in
 
EFPIA 2026 All rights reserved  ·  Disclaimer  ·  Unsubscribe